Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
asset sales
Pharma
AZ hands European Crestor rights to old customer Grünenthal
AZ has agreed to sign over Crestor rights in over 30 European countries—excluding the U.K. and Spain—for up to $350 million.
Angus Liu
Dec 1, 2020 10:50am
Streamlining Sanofi mulls drug sale that could snare $234M
Oct 19, 2020 10:10am
Takeda sells U.S. HQ, Latam brands for $940M
Mar 2, 2020 10:42am
AbbVie-Allergan could look to asset sales to offset Humira loss
Jan 7, 2020 8:49am
Sanofi plotting a stake sale to exit Bangladesh: report
Oct 16, 2019 10:28am
AstraZeneca backs away from acid reflux with Losec rights sale
Oct 2, 2019 9:55am
